Work

Profiling changes in metabolism and the immune microenvironment in lung tumorigenesis

Year: 2019

Type: article

Abstract: Lung cancer is the leading cause of cancer-related mortality worldwide, with 5-year survival rates still below 20% (1). Several multidisciplinary approaches are used clinically for the treatment of this disease. Depending on the type, classification, and staging of the lung tumor, patients are treated with surgery, radiotherapy, chemotherapy, or immunotherapy, alone or in combination.

Source: Annals of Translational Medicine

DOI: 10.21037/atm.2019.04.33

Authors: Di Zhang, Ana S. Leal, Fawzi Abu Rous, Karen T. Liby

Institution: Michigan State University

Language: English

Topic: Cancer, Hypoxia, and Metabolism

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: diamond

Funders: Breast Cancer Research Foundation, National Institutes of Health, National Cancer Institute, National Institute of General Medical Sciences